Common side effects (rare): Temporary fatigue in first 3-5 days Mild headaches Injection site redness Increased appetite Vivid dreams (uncommon) Serious side effects (very rare): Allergic reaction to peptide Injection site infection (poor technique) Dizziness or lightheadedness Who shouldn't use BPC-157: Pregnant or breastfeeding women Active cancer diagnosis (promotes angiogenesis) Recent retinal surgery (blood vessel growth in eye) Known allergy to peptides Drug interactions: BPC-157 doesn't interact with most medications, but combining with: NSAIDs: BPC-157 protects against NSAID damage (actually beneficial) Blood thinners: Monitor closely due to angiogenesis effects Immunosuppressants: May reduce BPC-157 effectiveness Dosing mistakes to avoid Get the protocol right from the start
Safe combinations include GLP-1 receptor agonists (semaglutide, tirzepatide), growth hormone secretagogues (CJC-1295, ipamorelin), and peptides with peripheral metabolic effects (AOD-9604)
Your clinician may recheck labs 710 days after starting (reticulocytes/hemoglobin) and again around 8 weeks (NHS)
If youve been feeling sluggish, foggy, or just not quite yourself, it might be time to consider a little B12 boost
Side effect profiles are similar in type (GI effects dominate both) but different in severity
B12 is the cleaning solution, and water is what helps it spread and do its job effectively